Đang chuẩn bị liên kết để tải về tài liệu:
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Lung cancer is the leading cause of cancer-related mortality. Therapies against non-small cell lung cancer (NSCLC) are particularly needed, as this type of cancer is relatively insensitive to chemotherapy and radiation therapy. |